Browsing: drug

Pathos AI Inc. todayannouncedthat it has raised $237 million in funding at a $3 billion valuation.

According to the latest IndexBox report on the global Drug Discovery Informatics market, the market enters 2026 with broader demand fundamentals, more disciplined procurement behavior, and a more regionally diversified supply architecture.

As former BigBang member T.O.P. and actress Nana went public with their relationship, Han Seo-hee, a former idol trainee who was previously embroiled in a drug scandal with T.O.P., showed a cool reaction.

[Sportschosun reporter Park A-ram] As former BigBang member T.O.P and actress Nana announced that they are dating, Han Seo-hee, whose name was previously mentioned alongside T.O.P in connection with a marijuana case, left a brief reaction.

The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print | Foley Hoag LLP

Basecamp Research Ltd. todayannouncedthat it has raised $140 million in funding from a group of prominent investors.

Leila Turner-Scott told Congress that her 19-year-old son, Sam Nelson, died from an accidental overdose after allegedly receiving unsafe guidance from ChatGPT

The government’s £500m fund to back a wave of promising AI companies is close to taking a stake in Potential Sciences, a drug discovery start-up.

ByteDance closed a $290M funding round for Anew Labs, its newly spun-off AI drug discovery unit, at a $1.5B valuation, Reuters reports, citing two sources familiar with the matter. Moreover, the company that owns TikTok will retain 56% of the business after this round, according to the same sources. 

The poor reader of today’s news is bombarded by articles hyping AI or their doom and gloom opposite. This dichotomy exists even in biopharma. Grand proclamations of the technology’s ability to accelerate novel drugs to market or sift through the scientific literature to find undiscovered targets run alongside articles that rail about how artificial intelligence…